JJJae-Hoon Ji

Jae-Hoon Ji

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jae-Hoon Ji has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Elizabeth V. Wasmuth

    Department of Biochemistry and Structural Biology, Greehey Children’s Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, USA

    3 shared publications
  • Weixing Zhao

    Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, USA

    3 shared publications
  • Youngho Kwon

    Department of Biochemistry and Structural Biology, the Center for Innovative Drug Discovery, and the Greehey Children’s Cancer Research Institute, the University of Texas Health Science Center San Antonio , San Antonio, TX 78229

    3 shared publications
  • Alexander V. Mazin

    Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA

    2 shared publications
  • Boya Gao

    Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, USA

    2 shared publications
  • Cody M. Rogers

    Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA

    2 shared publications

Latest Publications

  • Open Access

    HELZ-BRCA2 complex resolves R-loops to drive transcription-coupled homologous recombination

    by Wenjing Li, Bo Wu, Boya Gao, Elizabeth M. Irvin, Arijit Ghosh, Lillian Eliaz, Yuxin Huang, Youngho Kwon, Clara M. Stiefel, Tram Thi Ngoc Nguyen, et al.

    R-loops are transcription-induced, three-stranded nucleic acid structures that, if not properly resolved, can disrupt DNA repair and compromise genome stability. BRCA2, a tumor suppressor vital for homologous recombination (HR), also contributes to R-loop regulation, though the underlying mechanisms remain poorly understood. Here, we identify HELZ as a direct BRCA2 interactor and characterize it as an ssRNA-specific R-loop resolvase. BRCA2 enhances HELZ helicase activity and promotes its recruitment to R-loops. Importantly, HELZ resolves R-loops at DNA double-strand breaks, enabling efficient DNA end resection and HR, particularly within transcriptionally active genomic regions. We further demonstrate that HELZ is critical for R-loop clearance in cancers with elevated transcriptional activity and R-loop accumulation, such as estrogen receptor-positive breast cancer, where it becomes essential for cell survival under estrogen-induced transcriptional stress. These findings establish HELZ as a BRCA2-dependent regulator of R-loop homeostasis and identify it as a potential biomarker and therapeutic target in R-loop-driven malignancies.

  • Open Access

    GCN5 and TADA2B constitutively regulate XRCC1 function during DNA repair to maintain cell survival

    by Keeeun Kim, Junyoung Kim, Darom Lee, Jae-Hoon Ji, Myung-Hee Kwon, Byong Chul Yoo, Youngsoo Lee

    XRCC1 orchestrates base excision repair (BER) and single-strand break repair (SSBR) through protein-protein interactions, with disruption contributing to neurological diseases, including spinocerebellar ataxia autosomal recessive 26 (SCAR26). While PARP1-mediated recruitment is well established, constitutive regulatory mechanisms have remained unclear. Here, we identify GCN5 and TADA2B, components of the SAGA histone acetyltransferase complex, as novel XRCC1 binding partners providing constitutive regulation of repair localization. These proteins bind XRCC1 via distinct BRCT domain interactions—GCN5 to BRCT I, TADA2B to BRCT II—independent of DNA damage or GCN5 acetyltransferase activity. Depletion of either protein impairs DNA repair efficiency, sensitizes cells to genotoxic stress, and increases cell death, demonstrating their integral role in cell survival. Unexpectedly, GCN5 or TADA2B deficiency rescues focal retention defects in BRCT II deletion mutants, revealing how constitutive interactions optimize normal XRCC1 function but become counterproductive when XRCC1 is structurally compromised. In addition, the SCAR26-associated BRCT II point mutation disrupts TADA2B binding, yet paradoxically, this normally beneficial interaction becomes inhibitory in the mutant context. Our findings establish a ready-for-action model where repair complexes preorganize machinery before DNA damage occurs, revealing how constitutive regulation determines cellular responses to DNA damage.

  • Open Access

    Multifaceted roles of PDS5B in RAD51-dependent homology-directed DNA repair and replication fork protection

    by Jeffrey N. Katz, Lorena Samentar, Qingming Fang, Jae-Hoon Ji, Wenjing Li, Qiongmei Gao, Sahiti Kuppa, Boya Gao, Cody M. Rogers, Hardeep Kaur, et al.

    PDS5B (Precocious Dissociation of Sisters 5B) functions in sister chromatid cohesion and genome organization. Interestingly, PDS5B also associates with RAD51, the recombinase required for DNA damage repair by homologous recombination (HR) and the preservation of stressed DNA replication forks against nucleolytic attrition. We show that PDS5B binds dsDNA preferentially over ssDNA and that it enhances RAD51-mediated DNA strand exchange via the capture of dsDNA. PDS5B also acts synergistically with BRCA2-DSS1 to help overcome the interference of RPA in DNA strand exchange and works in conjunction with RAD51 to protect dsDNA against digestion by MRE11-RAD50-NBS1. DNA binding activity resides within the disordered C-terminal region of PDS5B, and testing of a DNA binding mutant provides evidence that this PDS5B attribute underpins protein functions in vitro and in HR and replication fork protection in cells. Our findings thus reveal distinct functions of PDS5B in genome repair and maintenance.

  • Open Access

    Structural insight into how RAD51 paralog exchange regulates RAD51 filament formation

    by Yashpal Rawal, Youngho Kwon, Lijia Jia, Eliza A. Ruben, Jae-Hoon Ji, Lijuan Guo, Caleb M. Stratton, Digant Nayak, Miriam Tovar, Qingming Fang, et al.

    Homologous recombination (HR) repairs DNA double-strand breaks and stabilizes stressed replication forks, and HR deficiency promotes genome instability and cancer. HR requires assembly of RAD51 nucleoprotein filaments on single-stranded DNA (ssDNA), a process regulated by the human RAD51 paralogs RAD51C, XRCC3, RAD51D and XRCC2. Here, using cryo-electron microscopy, we find that the RAD51-XRCC3-RAD51C complex (RAD51-X3C) assembles into an octamer in which XRCC3 engages the RAD51 DNA-binding surface and RAD51 subunits adopt a misaligned configuration incompatible with filament formation. These features define an autoinhibited RAD51-X3C state that limits nonproductive RAD51 binding to double-stranded DNA or RNA-DNA hybrids while preserving RAD51 availability for ssDNA-dependent strand exchange. We further show that the RAD51D-XRCC2 paralog complex remodels RAD51-X3C into a pentameric RAD51-X3CDX2 assembly by engaging the exposed RAD51C surface and disrupting contacts that stabilize the octamer. This remodeling exposes the RAD51 DNA-binding interface, enhances RAD51-ssDNA filament assembly, and promotes strand exchange on RPA-coated ssDNA, and yields a filament-compatible paralog assembly that integrates into ssDNA-bound RAD51 filaments. Together, these findings establish paralog exchange as a mechanism that converts an autoinhibited RAD51-X3C octamer into an activated RAD51-X3CDX2 pentamer to regulate RAD51 filament formation during HR and replication fork preservation.


  • Open Access

    PARP1-TRIM44-MRN loop dictates the response to PARP inhibitors

    by Yonghyeon Kim, Sunwoo Min, Soyeon Kim, Seo Yun Lee, Yeon-Ji Park, Yungyeong Heo, Soon Sang Park, Tae Jun Park, Jae-Ho Lee, Ho Chul Kang, et al.

    PARP inhibitors (PARPi) show selective efficacy in tumors with homologous recombination repair (HRR)-defects but the activation mechanism of HRR pathway in PARPi-treated cells remains enigmatic. To unveil it, we searched for the mediator bridging PARP1 to ATM pathways by screening 211 human ubiquitin-related proteins. We discovered TRIM44 as a crucial mediator that recruits the MRN complex to damaged chromatin, independent of PARP1 activity. TRIM44 binds PARP1 and regulates the ubiquitination-PARylation balance of PARP1, which facilitates timely recruitment of the MRN complex for DSB repair. Upon exposure to PARPi, TRIM44 shifts its binding from PARP1 to the MRN complex via its ZnF UBP domain. Knockdown of TRIM44 in cells significantly enhances the sensitivity to olaparib and overcomes the resistance to olaparib induced by 53BP1 deficiency. These observations emphasize the central role of TRIM44 in tethering PARP1 to the ATM-mediated repair pathway. Suppression of TRIM44 may enhance PARPi effectiveness and broaden their use even to HR-proficient tumors.